Skip to content
Home/Companies/Biotech/Mahzi Therapeutics

Mahzi Therapeutics

Biotech·US·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Mahzi Therapeutics?

Mahzi Therapeutics is currently owned by HealthCap through HealthCap VII (2016 vintage), since 2020.

Hand-verified · updated 2026-08-18

HealthCap
Investor
HealthCap
HealthCap VII · 2016 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from HealthCap VII

Other portfolio companies in the same fund.

Priothera Ltd.
Active
BiotechIreland· 2020
SynOx Therapeutics Ltd
Active
BiotechIreland· 2020
Carisma Therapeutics
Exited 2023
BiotechUS· 2018
to
InCarda Therapeutics Inc.
Active
BiotechUS· 2018
Modus Therapeutics
Modus Therapeutics
Active
BiotechSweden· 2018
Precirix
Active
BiotechBelgium· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Mahzi Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Mahzi Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Mahzi Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue